Reporting adverse events of ChAdOx1 nCoV-19 coronavirus vaccine (Recombinant) among the vaccinated healthcare professionals: A cross-sectional survey

被引:10
|
作者
Kaur, Sukhpal [1 ]
Singh, Ajay [2 ]
Saini, Sushma [1 ]
Rohilla, Latika [1 ]
Kaur, Jasvir [1 ]
Chandi, Anadeep [3 ]
Kaur, Gurpreet [1 ]
Singh, Manjeet [9 ]
Kumar, Pramod [1 ]
Soni, Shiv Lal [10 ]
Kajal, Kamal [2 ]
Naik, Naveen B. [2 ]
Malhotra, Pankaj [4 ]
Verma, Sanjay [5 ]
Gupta, Madhu [6 ]
Devnani, Mahesh [7 ]
Das, Karobi [1 ]
Pandav, S. S. [8 ]
Puri, G. D. [2 ]
机构
[1] Govt Multispecial Hosp, Natl Inst Nursing Educ, Dept Nursing, Chandigarh, India
[2] Govt Multispecial Hosp, Dept Anaesthesia & Intens Care, Chandigarh, India
[3] Govt Multispecial Hosp, Dept Obstet & Gynaecol, Chandigarh, India
[4] Govt Multispecial Hosp, Dept Internal Med, Chandigarh, India
[5] Govt Multispecial Hosp, Dept Paediat, Chandigarh, India
[6] Govt Multispecial Hosp, Dept Community Med, Chandigarh, India
[7] Govt Multispecial Hosp, Hosp Adm, Chandigarh, India
[8] Multispecial Hosp, Postgrad Inst Med Educ & Res, Ophthalmol, Chandigarh, India
[9] Govt Multispecial Hosp, Dept Med, Chandigarh, India
[10] Postgrad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Sect 12, Chandigarh 160012, India
关键词
Adverse events; ChAdOx1; nCoV-19; coronavirus disease 2019; healthcare professionals; side effects; vaccination;
D O I
10.4103/ijmr.ijmr_1221_21
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: The safety of the ChAdOx1 nCoV-19 vaccine is a cause of concern for many who have been vaccinated. The people have multiple concerns and fear regarding the adverse events of the vaccine. Thus, this study was undertaken to establish the safety profile of ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) among the healthcare professionals. Methods: This was a descriptive cross-sectional survey. After taking clearance from the institutional ethics committee 1500 healthcare professionals, who had their vaccination in the past two weeks were selected. They were provided with an online survey proforma regarding adverse events following immunization (AEFIs) of COVID-19 vaccine developed using google forms with an informed consent form affixed to it. Results: A total of 1036 individuals participated in the study. The mean and median (inter quartile range) age of the participants was 37.7 +/- 11.25 and 35 (29-46) yr, respectively. Of these, 52.1 per cent were female, 29.3 per cent were doctors, 33.4 per cent were nurses and 9.5 per cent were paramedical staff. Forty six per cent participants experienced one or more minor AEFIs such as pain, tenderness, redness, etc. at the injection site. Fatigue (31.75%), generalized feeling of unwell (28.57%), muscle pain (23.16%) and fever (21.71%) were the most commonly reported systemic AEFIs followed by headache (20.07%), dizziness (10.03%) and joint pains (15.25%). Most of them experienced these AEFIs within 24 h of the first dose of administration. About 42 per cent of the participants took oral antipyretics/analgesics for managing the AEFIs. Interpretation & conclusions: ChAdOx1 nCoV-19 Corona Virus Vaccine was found to be associated with mild local and systemic AEFIs that were more common after the first dose as compared to the second dose. There adverse events could be dealt with oral over-the-counter medications, with no requirement of hospitalization.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 50 条
  • [41] T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa
    McMahon, William C.
    Kwatra, Gaurav
    Izu, Alane
    Koen, Anthonet L.
    Greffrath, Johann
    Fairlie, Lee
    Patel, Faeezah
    Mukendi, Christian K.
    Mbele, Nkululeko J.
    Lala, Rushil
    Burgers, Wendy A.
    Nunes, Marta C.
    Cutland, Clare L.
    Gilbert, Sarah C.
    Lambe, Teresa
    Pollard, Andrew J.
    Madhi, Shabir A.
    AIDS, 2023, 37 (01) : 105 - 112
  • [42] Immune mediated events timely associated with COVID-19 vaccine. A comment on article by Badier, et al.: "IgA vasculitis in adult patients following vaccination by ChadOx1 nCoV-19"
    Hocevar, Alojzija
    Tomsid, Matija
    AUTOIMMUNITY REVIEWS, 2022, 21 (02)
  • [43] Determinants of COVID-19 vaccine uptake among healthcare professionals and the general population in Cyprus: A web-based cross-sectional survey
    Giannakou, Konstantinos
    Fakonti, Georgia
    Kyprianidou, Maria
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2022, 28 (06) : 959 - 969
  • [44] COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study
    Dziedzic, Arkadiusz
    Issa, Julien
    Hussain, Salman
    Tanasiewicz, Marta
    Wojtyczka, Robert
    Kubina, Robert
    Konwinska, Marta Dyszkiewicz
    Riad, Abanoub
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [45] Factors Associated with COVID-19 Vaccine Acceptance among Healthcare Professionals and Community Stakeholders in Hong Kong: A Cross-Sectional Study
    Lee, Regina Lai Tong
    Chien, Wai Tong
    Stubbs, Michelle
    Cheng, Winnie Lai Sheung
    Chiu, Daniel Cheung Shing
    Fung, Keith Hin Kee
    Cheng, Ho Yu
    Chong, Yuen Yu
    Tang, Anson Chui Yan
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (21)
  • [46] Anxiety, depression, and their associations with COVID-19-related knowledge, attitudes, and practices among healthcare professionals: a multinational cross-sectional survey
    Wei-Cheng Lo
    Yi-Chin Huang
    Yi-Hao Weng
    Mohammad Ainul Maruf
    Chung Bui
    Mei-Hui Lee
    Kang-Yun Lee
    Mai-Szu Wu
    Ya-Wen Chiu
    Hung-Yi Chiou
    BMC Psychology, 13 (1)
  • [47] Adverse reactions and production of neutralizing anti-SARS-CoV-2 antibodies after ChAdOx1 COVID-19 vaccination: A cross-sectional study in a single center
    Jeong, Yeon Jeong
    Kim, Youn Jeong
    Kim, Si Hyun
    Yoo, Jaeeun
    Lee, Jaewoong
    Lee, Seungok
    Kim, Sang Il
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (03) : 360 - 364
  • [48] Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI)
    Stirrup, Oliver
    Krutikov, Maria
    Tut, Gokhan
    Palmer, Tom
    Bone, David
    Bruton, Rachel
    Fuller, Chris
    Azmi, Borscha
    Lancaster, Tara
    Sylla, Panagiota
    Kaur, Nayandeep
    Spalkova, Eliska
    Bentley, Christopher
    Amin, Umayr
    Jadir, Azar
    Hulme, Samuel
    Giddings, Rebecca
    Nacer-Laidi, Hadjer
    Baynton, Verity
    Irwin-Singer, Aidan
    Hayward, Andrew
    Moss, Paul
    Copas, Andrew
    Shallcross, Laura
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (11) : 1877 - 1881
  • [49] A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naive Individuals: A Longitudinal Study in Ethiopian Health Workers
    Gelanew, Tesfaye
    Mulu, Andargachew
    Abebe, Markos
    Bates, Timothy A.
    Wassie, Liya
    Teferi, Mekonnen
    Fentahun, Dessalegn
    Alemu, Aynalem
    Tamiru, Frehiwot
    Assefa, Gebeyehu
    Bayih, Abebe Genetu
    Tafesse, Fikadu G.
    Mihret, Adane
    Abdissa, Alemseged
    VACCINES, 2022, 10 (06)
  • [50] Cross-Sectional Survey on BNT162b2 mRNA COVID-19 Vaccine Serious Adverse Events in Children 5 to 11 Years of Age: A Monocentric Experience
    Bloise, Silvia
    Marcellino, Alessia
    Frasacco, Beatrice
    Gizzone, Pietro
    Proietti Ciolli, Claudia
    Martucci, Vanessa
    Sanseviero, Mariateresa
    Del Giudice, Emanuela
    Ventriglia, Flavia
    Lubrano, Riccardo
    VACCINES, 2022, 10 (08)